These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 9566484

  • 21. Low-dose continuous iron therapy leads to a positive iron balance and decreased serum transferrin levels in chronic haemodialysis patients.
    Canavese C, Bergamo D, Ciccone G, Burdese M, Maddalena E, Barbieri S, Thea A, Fop F.
    Nephrol Dial Transplant; 2004 Jun; 19(6):1564-70. PubMed ID: 15004263
    [Abstract] [Full Text] [Related]

  • 22. The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin.
    Tessitore N, Solero GP, Lippi G, Bassi A, Faccini GB, Bedogna V, Gammaro L, Brocco G, Restivo G, Bernich P, Lupo A, Maschio G.
    Nephrol Dial Transplant; 2001 Jul; 16(7):1416-23. PubMed ID: 11427634
    [Abstract] [Full Text] [Related]

  • 23. Hypochromic red cells and reticulocyte haemglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis.
    Cullen P, Söffker J, Höpfl M, Bremer C, Schlaghecken R, Mehrens T, Assmann G, Schaefer RM.
    Nephrol Dial Transplant; 1999 Mar; 14(3):659-65. PubMed ID: 10193816
    [Abstract] [Full Text] [Related]

  • 24. Hypochromic red blood cells and reticulocytes.
    Schaefer RM, Schaefer L.
    Kidney Int Suppl; 1999 Mar; 69():S44-8. PubMed ID: 10084285
    [Abstract] [Full Text] [Related]

  • 25. Limited value of zinc protoporphyrin as a marker of iron status in chronic hemodialysis patients.
    Canavese C, Grill A, Decostanzi E, Maddalena E, Barbieri S, Martina G, Fop F, Buglione E, Grechi D, David O, Saitta M, Piccoli G.
    Clin Nephrol; 2000 Jan; 53(1):42-7. PubMed ID: 10661481
    [Abstract] [Full Text] [Related]

  • 26. Nomogram for individualizing supplementary iron doses during erythropoietin therapy in haemodialysis patients.
    Kadota K, Kamata K, Kobayashi Y, Kagaya H, Shimada S, Yoshimoto-Furuie K, Echizen H.
    J Clin Pharm Ther; 2002 Apr; 27(2):111-9. PubMed ID: 11975695
    [Abstract] [Full Text] [Related]

  • 27. The hypochromic red cell: a new parameter for monitoring of iron supplementation during rhEPO therapy.
    Schaefer RM, Schaefer L.
    J Perinat Med; 1995 Apr; 23(1-2):83-8. PubMed ID: 7658326
    [Abstract] [Full Text] [Related]

  • 28. Is zinc protoporphyrin an indicator of iron-deficient erythropoiesis in maintenance haemodialysis patients?
    Braun J, Hammerschmidt M, Schreiber M, Heidler R, Hörl WH.
    Nephrol Dial Transplant; 1996 Mar; 11(3):492-7. PubMed ID: 8671820
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response.
    Rutherford CJ, Schneider TJ, Dempsey H, Kirn DH, Brugnara C, Goldberg MA.
    Am J Med; 1994 Feb; 96(2):139-45. PubMed ID: 8109598
    [Abstract] [Full Text] [Related]

  • 30. Experience with zinc protoporphyrin as a marker of endogenous iron availability in chronic haemodialysis patients.
    Baldus M, Salopek S, Möller M, Schliesser J, Klooker P, Reddig J, Gansert U, Brass H.
    Nephrol Dial Transplant; 1996 Mar; 11(3):486-91. PubMed ID: 8710158
    [Abstract] [Full Text] [Related]

  • 31. Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients.
    Chang J, Bird R, Clague A, Carter A.
    Pathology; 2007 Jun; 39(3):349-53. PubMed ID: 17558864
    [Abstract] [Full Text] [Related]

  • 32. Iron deficiency and erythropoiesis: new diagnostic approaches.
    Brugnara C.
    Clin Chem; 2003 Oct; 49(10):1573-8. PubMed ID: 14500582
    [Abstract] [Full Text] [Related]

  • 33. Factors determining the percentage of hypochromic red blood cells in hemodialysis patients.
    Bovy C, Tsobo C, Crapanzano L, Rorive G, Beguin Y, Albert A, Paulus JM.
    Kidney Int; 1999 Sep; 56(3):1113-9. PubMed ID: 10469381
    [Abstract] [Full Text] [Related]

  • 34. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia.
    Tarng DC, Wei YH, Huang TP, Kuo BI, Yang WC.
    Kidney Int; 1999 Jun; 55(6):2477-86. PubMed ID: 10354297
    [Abstract] [Full Text] [Related]

  • 35. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
    Riedel MK, Morgenstern T.
    Dtsch Med Wochenschr; 2004 Sep 03; 129(36):1849-53. PubMed ID: 15368155
    [Abstract] [Full Text] [Related]

  • 36. [The biochemical and hematological assessment of iron metabolism].
    Nathanson S, Deschênes G, Bensman A.
    Arch Pediatr; 1999 Nov 03; 6(11):1199-204. PubMed ID: 10587746
    [Abstract] [Full Text] [Related]

  • 37. A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients.
    Johnson DW, Herzig KA, Gissane R, Campbell SB, Hawley CM, Isbel NM.
    Nephrol Dial Transplant; 2001 Sep 03; 16(9):1879-84. PubMed ID: 11522873
    [Abstract] [Full Text] [Related]

  • 38. A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes.
    Parisotto R, Gore CJ, Emslie KR, Ashenden MJ, Brugnara C, Howe C, Martin DT, Trout GJ, Hahn AG.
    Haematologica; 2000 Jun 03; 85(6):564-72. PubMed ID: 10870111
    [Abstract] [Full Text] [Related]

  • 39. Characterization of the anaemia of chronic renal failure and the mode of its correction by a preparation of human erythropoietin (r-HuEPO). An investigation of the pharmacokinetics of intravenous erythropoietin and its effects on erythrokinetics.
    Cotes PM, Pippard MJ, Reid CD, Winearls CG, Oliver DO, Royston JP.
    Q J Med; 1989 Feb 03; 70(262):113-37. PubMed ID: 2594953
    [Abstract] [Full Text] [Related]

  • 40. Oral vitamin C supplementation reduces erythropoietin requirement in hemodialysis patients with functional iron deficiency.
    Sultana T, DeVita MV, Michelis MF.
    Int Urol Nephrol; 2016 Sep 03; 48(9):1519-24. PubMed ID: 27170339
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.